SCHEMBL6476773

SCHEMBL6476773

CN1CC2CN(c3nc4ccccc4n3C3CCN(C4(c5ccccc5)CCCCCC4)CC3)CC2C1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 14/20 0.58
OPRK1 P41145 13/20 0.58
OPRL1 P41146 12/20 0.58
OPRD1 P41143 7/20 0.58
KCNH2 Q12809 2/20 0.57
OGFRL1 Q5TC84 5/20 0.52
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
CYP2B6 P20813 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
PRCP P42785 1/20 0.41
SLC6A3 Q01959 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6483596 0.89 OPRM1 (0.59) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL7095645 0.89 OPRM1 (0.71) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL7094032 0.89 OPRM1 (0.71) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL7095902 0.89 OPRM1 (0.71) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL6214946 0.89 OPRM1 (0.72) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL6482596 0.87 OPRM1 (0.75) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL7095606 0.87 OPRM1 (0.58) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL7091407 0.87 OPRM1 (0.58) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL7093813 0.87 OPRM1 (0.58) OPRM1OPRK1OPRL1OPRD1KCNH2
SCHEMBL6484497 0.85 OPRM1 (0.61) OPRM1OPRK1OPRL1OPRD1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861425-B2 Benzimidazole compounds as ORL1-receptor agonists PFIZER, INC. (US) 2005-03-01 US disclosed
US-20020049212-A1 Benzimidazole compounds as ORL1-receptor agonists PFIZER PRODUCTS INC. 2002-04-25 US disclosed
EP-1122257-A1 Benzimidazole compounds as ORL1-receptor agonists PFIZER INC. (US) 2001-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049212-A1 Benzimidazole compounds as ORL1-receptor agonists OPRL1, ORMDL3, OGFRL1 OPRM1 4/4885OPRK1 8/4885OPRL1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.